Lidanserin (INN; ZK-33,839) is a drug which acts as a combined 5-HT2A and α1-adrenergic receptor antagonist.[1] It was developed as an antihypertensive agent but was never marketed.
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Lidanserin".
Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2025, A B Cryer, All Rights Reserved. Cookie policy.